Standout Papers

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with ad... 2009 2026 2014 2020 570
  1. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial (2009)
    Yoon‐Koo Kang, Won Ki Kang et al. Annals of Oncology

Immediate Impact

2 from Science/Nature 89 standout
Sub-graph 1 of 19

Citing Papers

Oesophageal cancer
2024 Standout
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
1 intermediate paper

Works of P. McCloud being referenced

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
2009 Standout
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
2009

Author Peers

Author Last Decade Papers Cites
P. McCloud 710 87 424 369 16 1.1k
M. Horowitz 260 44 237 299 31 1.2k
Chris Dudley 291 57 57 349 27 1.2k
Roxanne Cosby 257 91 322 291 29 1.2k
M B McIllmurray 255 206 569 131 32 1.2k
Herbert Brill 191 153 207 480 37 1.2k
Stanley Williams 187 9 298 713 24 1.1k
Jamil S. Samaan 131 12 126 285 43 988
Paul Celano 233 43 189 177 24 1.2k
Anasooya Abraham 226 26 439 601 20 1.1k
Tracy Slanger 272 46 356 281 22 1.2k

All Works

Loading papers...

Rankless by CCL
2026